BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 918347)

  • 1. Multiple factors affecting excretion of warfarin in rats.
    Pepper ES; Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):275-81. PubMed ID: 918347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of oleic acid, tolbutamide, and oxyphenbutazone on the binding of warfarin by human serum albumin.
    Wosilait WD; Ryan MP
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):577-84. PubMed ID: 504792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of oxyphenbutazone on the excretion of 14 C-warfarin in the bile of rat.
    Wosilait WD; Eisenbrandt LL
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):413-20. PubMed ID: 5074533
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of novibiocin and tolbutamide on the excretion of warfarin in the bile of rats.
    Wosilait WD; Eisenbrandt LL
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):109-16. PubMed ID: 4686095
    [No Abstract]   [Full Text] [Related]  

  • 5. Competition between diftalone and other drugs for the binding site(s) on human serum albumin.
    Assandri A; Perazzi A
    Med Biol; 1976 Jun; 54(3):187-92. PubMed ID: 940363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of fasting on the disposition of warfarin in rats.
    Laliberte R; Chakrabarti S; Brodeur J
    J Pharmacol Exp Ther; 1977 Jan; 200(1):44-51. PubMed ID: 833761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competition between serum albumin and soluble fraction of liver for binding of warfarin and other drugs.
    Wosilait WD; Ryan MP; Byington KH
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):113-21. PubMed ID: 7291718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between the dose of warfarin, free drug in plasma, and its elimination in the bile of rats.
    Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):943-50. PubMed ID: 4760900
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of fasting and stress on the response of rats to warfarin.
    Laliberté R; Chakrabarti S; Brodeur J
    J Pharmacol Exp Ther; 1976 Jan; 196(1):194-203. PubMed ID: 54416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
    Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
    Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the intestinal microflora on the elimination of warfarin in the rat.
    Remmel RP; Pohl LR; Elmer GW
    Drug Metab Dispos; 1981; 9(5):410-4. PubMed ID: 6117438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative interaction of sulfinpyrazone and phenylbutazone with racemic warfarin: alteration in vivo of free fraction of plasma warfarin.
    O'Reilly RA; Goulart DA
    J Pharmacol Exp Ther; 1981 Dec; 219(3):691-4. PubMed ID: 7299692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ethinyl estradiol and phenobarbital on bile acid synthesis and biliary bile acid and cholesterol excretion.
    Davis RA; Kern F
    Gastroenterology; 1976 Jun; 70(6):1130-5. PubMed ID: 1269874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of BSP and rifamycin on the excretion of warfarin in the bile of the rate.
    Wosilait WD
    Gen Pharmacol; 1977; 8(5-6):349-53. PubMed ID: 604160
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of phenylbutazone, tolbutamide, and clofibric acid on binding of racemic warfarin and its enantiomers to human serum albumin.
    Veronich K; White G; Kapoor A
    J Pharm Sci; 1979 Dec; 68(12):1515-8. PubMed ID: 529041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on the allosteric interaction between the major binding sites of human serum albumin using microcalorimetry.
    Dröge JH; Janssen LH; Wilting J
    Biochim Biophys Acta; 1985 Mar; 827(3):396-402. PubMed ID: 3970944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dietary cholesterol on bile formation and hepatic processing of chylomicron remnant cholesterol in the rat.
    Smit MJ; Kuipers F; Vonk RJ; Temmerman AM; Jäckle S; Windler EE
    Hepatology; 1993 Mar; 17(3):445-54. PubMed ID: 8444419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
    Maes V; Engelborghs Y; Hoebeke J; Maras Y; Vercruysse A
    Mol Pharmacol; 1982 Jan; 21(1):100-7. PubMed ID: 7132952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
    Fehske KJ; Schläfer U; Wollert U; Müller WE
    Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.